# Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

Study · id `cardio:ct-nct02444442` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02444442](<https://clinicaltrials.gov/study/NCT02444442>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02444442

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 105 participants.

## Technical summary

Registry record NCT02444442. Randomized; double masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2020-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 105 participants (planned count; ClinicalTrials.gov record NCT02444442, source copy `cardio:ctgov-nct02444442-2023-09-14`, retrieved 2026-10-26)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT02444442, source copy `cardio:ctgov-nct02444442-2023-09-14`, retrieved 2026-10-26)
- Primary completion: 2020-04 (actual) (ClinicalTrials.gov record NCT02444442, source copy `cardio:ctgov-nct02444442-2023-09-14`, retrieved 2026-10-26)
- Completion: 2020-04 (actual) (ClinicalTrials.gov record NCT02444442, source copy `cardio:ctgov-nct02444442-2023-09-14`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT02444442, source copy `cardio:ctgov-nct02444442-2023-09-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02444442-2023-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension
- Condition: Hypertension
- Intervention (Device): Renal Denervation
- Intervention (Other): Sham control
- Lead sponsor: Baker Heart and Diabetes Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Baker Heart and Diabetes Institute (`cardio:org-baker-heart-and-diabetes-institute`)

## Provenance

Content hash: ca1ce5b6f260af64e8a195088fe74bf06146b958a7791e9d1ec7475c2c82200a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
